SCHEMBL6554977

SCHEMBL6554977

C#Cc1cc(C)cc(C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
TSHR P16473 2/20 0.40
CYP1A1 P04798 1/20 0.37
CYP1B1 Q16678 1/20 0.37
ACHE P22303 2/20 0.36
SELL P14151 1/20 0.36
SELP P16109 1/20 0.36
SELE P16581 1/20 0.36
HDAC8 Q9BY41 5/20 0.36
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
CA14 Q9ULX7 2/20 0.32
CA4 P22748 1/20 0.32
TPMT P51580 1/20 0.32
PRSS1 P07477 1/20 0.31
PRSS2 P07478 1/20 0.31
C1S P09871 1/20 0.31
PRSS3 P35030 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29287702 0.87 ALDH1A1 (0.57) ALDH1A1TSHRCYP1A1CYP1B1ACHE
SCHEMBL26377782 0.82 ACHE (0.36) CYP1A1CYP1B1ACHEHDAC8
SCHEMBL18934332 0.82 ALDH1A1 (0.42) ALDH1A1CYP1A1CYP1B1
SCHEMBL7039619 0.82 ALDH1A1 (0.55) ALDH1A1TSHRCYP1A1CYP1B1ACHE
SCHEMBL13982141 0.82 RAPGEF4 (0.33) TSHRCYP1A1CYP1B1HDAC8
SCHEMBL17552583 0.78 ALDH1A1 (0.42) ALDH1A1TSHRCYP1A1CYP1B1ACHE
SCHEMBL20633339 0.77 IDO1 (0.38)
SCHEMBL211753 0.75 CYP1A1 (0.46) CYP1A1CYP1B1HDAC8CA12CA1
SCHEMBL23235858 0.75 GRM5 (0.32)
SCHEMBL13671476 0.75 TPMT (0.61) ALDH1A1TSHRSELLSELPCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113735672-A Preparation method of fully-substituted 1-butene-3-alkyne derivative 昆明理工大学 2021-12-03 CN claimed
CN-111533684-B Method for alkenylating pyridine compound 四川大学 2021-10-29 CN claimed
CN-111808071-A Method for synthesizing polysubstituted aminoisoquinoline compound by cyclization of pyridine and alkyne under catalysis of rhodium 中国科学院兰州化学物理研究所 2020-10-23 CN claimed
CN-111533684-A Method for alkenylating pyridine compound 四川大学 2020-08-14 CN claimed
CN-118324603-A Method for synthesizing chrysene derivatives through palladium-catalyzed cycloaromatization reaction 湖南师范大学 2024-07-12 CN disclosed
CN-114409669-B C-5 alkynyl substituted cantharidin derivative on oxanorbornene ring and preparation method and application thereof 云南民族大学 2023-06-23 CN disclosed
CN-111233827-B 2,5-disubstituted selenophene compound and synthetic method thereof 华南理工大学 2022-10-25 CN disclosed
US-11345665-B2 Chiral 1,3-diarylimidazolium salt carbene precursor, synthesis method therefor, metal salt compound and application thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2022-05-31 US disclosed
CN-114409669-A C-5 alkynyl substituted cantharidin derivative on oxanorbornene ring and preparation method and application thereof 云南民族大学 2022-04-29 CN disclosed
CN-111808071-B Method for synthesizing polysubstituted aminoisoquinoline compound by cyclization of pyridine and alkyne under catalysis of rhodium 中国科学院兰州化学物理研究所 2022-03-25 CN disclosed
CN-109776422-B Chiral 1, 3-diaryl imidazole salt carbene precursor, synthesis method thereof, metal salt compound and application 中国科学院上海有机化学研究所 2022-01-14 CN disclosed
CN-113735672-A Preparation method of fully-substituted 1-butene-3-alkyne derivative 昆明理工大学 2021-12-03 CN disclosed
EP-0868178-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE Merck & Co., Inc. (US) 1998-10-07 EP disclosed
US-5756507-A TREATING SEX HORMONE RELATED DISORDERS MERCK & CO., INC. (US) 1998-05-26 US disclosed
WO-1997021435-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO., INC. (US) 1997-06-19 WO disclosed
EP-0410361-B1 Process for producing styrene polymers IDEMITSU KOSAN CO (JP) 1996-02-28 EP disclosed
EP-0662465-A1 A purifying method of a styrene monomer IDEMITSU KOSAN COMPANY LIMITED (JP) 1995-07-12 EP disclosed
EP-0410361-A2 Process for producing styrene polymers IDEMITSU KOSAN COMPANY LIMITED (JP) 1991-01-30 EP disclosed
US-4024273-A Coronary vasodilator and anti-anginal compositions comprising substituted benzofurans and benzothiophenes and methods of producing coronary vasodilation and anti-anginal activity SMITHKLINE CORPORATION (US) 1977-05-17 US disclosed
US-3947470-A CORONARY VASODILATORS, TREATMENT OF ANGINA PECTORIS SMITHKLINE CORPORATION (US) 1976-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11345665-B2 Chiral 1,3-diarylimidazolium salt carbene precursor, synthesis method therefor, metal salt compound and application thereof CYP51A1, SLC39A11, ZC3HAV1L ALDH1A1 777/4885TSHR 4702/4885CYP1A1 156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.